Investor Presentaiton
OUR VALUE CREATION | Intellectual capital
Check out Open D'Or's main achievements in 2021:
1,576
POTENTIAL PARTNERS MAPPED
0
329
571
1,178
1,576
10
3
13
MARKET
STUDIES
TECHNICAL VISITS
IMPORTANT
PARTNERSHIPS
with startups, companies,
science and technology
institutes
PRODUCTS UNDER
DEVELOPMENT
2017
2018
2019
2020
2021
鸭 10
1
PATENT
SPIN-OFF
3
SOFTWARE
AND HARDWARE
LICENSES
with 4,000 volunteers in two cities, Rio
de Janeiro and Salvador. The preparation
involved structural investments, selection
and training of 100 people to recruit,
administer the vaccine and monitor
volunteers for 1 year (the period of the
trial). Afterwards, other four studies with
different vaccines (a total of five Covid-19
vaccines studies) became part of IDOR's
initiatives to fight Covid-19, amounting to
6,600 volunteers.
In addition to the concern about the
disease's physiological aspects and
vaccines to prevent it, IDOR also acted
to soften the negative impacts of the
pandemic on the population's mental
health, creating an online and free-of-
charge platform to periodically make
tips and exercises available based on
scientific evidence to improve anxiety and
depression symptoms, as well as other
wellness tips. IDOR Mental Health Portal is
run by IDOR's psychology and psychiatry
professionals and recorded more than
60,000 hits in one single day.
In partnership with Zoox Smart Data,
IDOR also developed "Dados do Bem"
an app to analyze the geographic area
infected by Covid-19. The tool was
adopted by several municipal authorities
to help devising strategic plans to fight
the disease, providing guidance on
exams and management of physical
space. The app recorded more than 1.5
million downloads and was used by more
than 1 million people to perform a self-
evaluation and recommended to 250,000
people to go and get tested for the
disease. The Dados do Bem app ended
its main activities in March 2021, however
it remains available for public authorities
according to the pandemic needs.
IDOR actions during the pandemic
To fight the new coronavirus pandemic,
IDOR rallied most of its researchers
and employees to implement a broad
research platform on Covid-19, with 10
study fronts. "IDOR Science against
Covid-19" encompasses research about
understanding the virus behavior in
laboratory and its effects in different
cells and tissues, drug trials to neutralize
or reduce the virus' effects, recognize
the disease's biological markers in order
to predict its outcomes, clinical trials for
101 REDE D'OR SÃO LUIZ | Annual Sustainability Report 2021
patients with different comorbidities,
cellular therapies, evaluation of fear and
lockdown impacts and the use of artificial
intelligence in radiologic image analysis.
These efforts already have resulted in
more than 110 studies published in several
international science journals and caught
the attention of several international
scientific events.
IDOR became ready in just a few weeks
to carry out the Oxford's vaccine trials
COVID-19
Oxford Vaccine Trial
ESTUDO VACINA COVID-19
INSTITUTO
POR
PESQUISA E ENSINO
REDE POR
SÃO LUIZ
From the left to the right: Dr.
Ana Pittella, main researcher in
the vaccine trials at IDOR-RJ,
Dr. Sue Ann Costa Clemens,
representative of Oxford's
vaccine trials in Brazil, Dr.
Andrew Pollard, director of
Oxford University's Vaccine
Group and Dr. Fernanda Tovar-
Moll, president of IDOR.View entire presentation